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pHLipids are best known for their structural role in forming 
lipid bilayers in cells, which facilitates inter- and intra-
cellular compartmentalization. However, prominent roles 
for several lipids in signal transduction have also emerged 
in  the  past  decade  [1-3].  Phosphatidic  acid  (PA)  is  an 
anionic lipid consisting of a negatively charged phospho-
monoester  headgroup  attached  to  a  hydrophobic 
diacylglycerol  backbone  (Figure  1).  It  is  present  in  all 
organisms and serves as a key intermediate in the syn-
thesis  of  neutral  lipids  (di-  and  triacylglycerol)  and  all 
glycerophospholipids [4-6]. These include phosphatidyl-
serine  (PS),  phosphatidylethanolamine  (PE),  phos  pha-
tidyl  choline  (PC),  phosphatidylinositol  (PI),  and  the 
phos  phatidylinositol  phosphates  (PIPs),  which  together 
make up the bulk of cellular membranes (Figure 1) [4,5]. 
In  addition,  PA  is  emerging  as  an  important  signaling 
lipid.
Signaling lipids in general are thought to act by binding 
effector  proteins  and  recruiting  them  to  a  membrane, 
which regulates the proteins’ activity in cellular pathways. 
Binding is primarily dependent on the concentration of 
the lipid in the bilayer. Changes in lipid concentration 
induced by lipid-modifying enzymes in response to up-
stream signals generate downstream signaling responses 
(Figure 2) [3]. For PA, its concentration is maintained at 
low  levels  in  the  cell  as  a  result  of  its  continuous 
conversion into other lipid species, which balances its de 
novo synthesis [4,5]. For this reason PA makes up only 
around 1% of total cellular lipid content [7]. However, PA 
can also be produced from lipid reserves, such as through 
the hydrolysis of PC by phospholipase D (PLD) and the 
phosphorylation of diacylglycerol (DAG) by DAG kinase 
(DGK), and these routes have important signaling roles 
(Figure 1) [3].
PLD activation is the best-characterized route by which 
cells generate PA in signaling responses [8,9]. In mam-
malian cells, PLD is a potent regulator of the Ras signal-
ing pathway, which is strongly implicated in cancer and 
well known to regulate cell proliferation, differen  tiation 
and  apoptosis  [10,11].  In  this  case,  stimulation  by 
epidermal growth factor results in increased activity of 
PLD at the plasma membrane and generation of localized 
PA at this site [10]. Generation of PA leads to the binding 
and recruitment of the effector protein Son of sevenless 
(Sos)  to  the  plasma  membrane,  which  leads  to  Ras 
activation [10]. Similarly, the kinase Raf-1 is activated by 
PA  generated  by  PLD,  which  results  in  activation  of 
downstream mitogen-activated protein kinase signaling 
[12-14].  In  addition,  PA  can  bind  and  activate  the 
mammalian  target  of  rapamycin  (mTOR),  a  protein 
kinase well known for its roles in cell survival and cancer 
[15,16]. This activation by PA has also been linked to PLD 
regulation [17]. Sphingosine kinase, which has important 
roles  in  cell  growth,  calcium  homeostasis  and  cell 
movement  [18],  is  also  regulated  by  PLD-  and  PA-
dependent recruitment to intracellular membranes [19]. 
In  yeast,  PA  signaling  is  required  for  sporulation,  the 
yeast equivalent of gametogenesis [20,21]. PLD is respon-
sible for generating PA during this event, which activates 
the membrane recruitment of the SNARE protein Spo20, 
which  in  turn  drives  formation  of  the  prospore 
membrane [20-22].
PA  signaling  has  also  been  strongly  implicated  in 
numerous  other  cellular  processes,  including  vesicular 
trafficking,  cytoskeletal  dynamics  and  stress  responses 
[3,23]. Despite the detailed characterization of the many 
pathways regulated by PA, the mechanisms underlying its 
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in cell signaling and metabolic regulation in all 
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changes in pH to intracellular signaling pathways. 
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signaling lipids also contain headgroups with 
phosphomonoesters, implying that pH sensing by 
lipids may be widespread in biology.
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important question is how do proteins recognize PA over 
other abundant anionic lipids, such as PS and PIPs. A 
second and related question is how is PA in a particular 
membrane recognized over PA in another, as the lipid is 
present  in  most  intracellular  membranes  at  similar 
concentrations,  but  binding  of  effectors  appears  to  be 
membrane specific [12,24]. Answering these questions is 
critical to understanding the regulation of PA signaling 
and is of clinical importance because of emerging roles 
for  PA  and  its  protein  effectors  in  disease,  especially 
cancer  [16,17,25].  In  this  review,  we  will  discuss  these 
questions  by  introducing  how  charge  and  pH  govern 
effector  binding  and  how  PA  signaling  is  regulated  by 
intracellular pH.
Interaction	of	proteins	with	phosphatidic	acid
We  will  start  by  discussing  how  PA  interacts  with  its 
effector  proteins  and  how  specificity  is  likely  to  be 
achieved.  PA  effectors  are  different  from  other  lipid-
binding proteins because they lack an obvious conserved 
primary amino acid sequence [23,26]. Instead, binding to 
PA is generally specified through nonspecific electrostatic 
interactions between clusters of positively charged amino 
acids in the protein and the negatively charged phos  pho-
monoester headgroup of PA [14,20,24,26-28]. In addition, 
most  PA-binding  domains  also  contain  interspersed 
hydrophobic  residues  that  are  thought  to  facilitate 
membrane  association  through  their  insertion  into  the 
bilayer [26,29]. PS is another negatively charged lipid that 
is nearly 10-fold more abundant than PA in cells and is 
the  predominant  anionic  species  in  the  plasma  mem-
brane, comprising around 34% of total plasma membrane 
phospholipids;  and  PS  effectors  also  employ  similar 
binding strategies [7,26]. Yet rarely do PA effectors also 
bind PS. A key question, therefore, is how is specificity 
for PA achieved?
PA is unique among phospholipids in that it contains a 
phosphomonoester headgroup rather than the phos  pho-
diesters in other phospholipids such as PS, in which the 
phosphate  group  is  also  linked  to  a  serine  (Figure  1). 
Work by Kooijman et al. [27] revealed that the charge 
Figure 1. Phosphatidic acid is a key precursor in lipid metabolism. A simplified outline of the major lipids originating from phosphatidic 
acid (PA) is shown. These include glycerophospholipids: CDP-diacylglycerol (CDP-DAG), phosphatidylserine (PS), phosphatidylethanolamine 
(PE), phosphatidylcholine (PC), phosphatidylinositol (PI), and phosphoinositol phosphates (PIPs); and neutral lipids: diacylglycerol (DAG) and 
triacylglycerol (TAG). PA is drawn in its deprotonated form carrying a charge of 2-. Its structure is composed of a phosphomonoester headgroup 
(shown in red) attached to a DAG backbone (highlighted in yellow). This DAG backbone is composed of glycerol with two acyl chains attached at 
its sn1 and sn2 positions (green numerals indicate the sn positions of glycerol, R represents the remaining structure of each acyl chain that is not 
shown). All glycerophospholipids have their headgroups attached to the DAG backbone at the sn3 position of glycerol. The headgroups of PS, PE, 
PC and PI are shown for comparison and the positions of phosphorylation of the inositol ring in PIPs are labeled (3,4,5). The actions of DAG kinase 
(DGK) and phospholipase D (PLD) in regulating PA levels are also indicated (shown in blue italics).
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of other anionic lipids, is key to achieving specificity in 
effector binding. Kooijman et al. [30] first shed light on 
the nature of PA recognition by using 31P-NMR to study 
the  ionization  state  of  PA  and  lysophosphatidic  acid 
(LPA) in model membrane bilayers. LPA, like PA, has a 
phosphomonoester  headgroup,  but  differs  in  that  its 
second  acyl  chain  is  replaced  by  a  hydroxyl  group 
(Figure 3a). Kooijman et al. discovered that LPA has a 
significantly lower pKa than PA (7.5 for LPA compared 
with 7.9 for PA) and therefore carries significantly greater 
negative  charge  at  physiological  pH  [30]  (pKa  is  the 
negative logarithm of the ionization constant of an acid). 
This  difference  was  attributed  to  hydrogen  bonding 
between the phosphomonoester of LPA and the hydroxyl 
group  replacing  its  missing  acyl  chain  (Figure  3a). 
Interestingly, inclusion of PE, another excellent hydrogen-
bond donor, in model membranes lowered the pKa values 
of both PA and LPA even further, to the same value of 6.9. 
On this evidence, the authors proposed a model in which 
hydrogen  bonding  of  the  effector  protein  to  the 
phosphomonoester  of  PA  enables  it  to  carry  a  greater 
negative  charge  at  physiological  range  [30].  Hydrogen 
bonding  between  the  hydroxyl  oxygens  of  PA  and 
hydrogen-bond donors, such as the primary amines of 
PE, results in destabilization of the remaining proton of 
the phosphate, probably as a result of increased compe-
tition for oxygen electrons (Figure 3b). This facilitates the 
dissociation  of  this  proton,  which  ultimately  increases 
the negative charge of PA.
Lysines  and  arginines  in  proteins  also  represent  an 
excellent  source  of  hydrogen-bond  donors  because  of 
their  primary  amines.  Therefore,  a  key  question  was 
whether hydrogen bonding between the phospho  mono-
ester  of  PA  and  lysines  and  arginines  in  PA-binding 
domains had a role in binding specificity. Kooijman et al. 
[29]  demonstrated  that  small  peptides  composed  of 
lysine and arginine residues also increase the charge of 
PA,  probably  as  a  result  of  hydrogen  bonding.  This 
culminated in the proposal of the ‘electrostatic/hydrogen-
bond  switch  mechanism’,  which  provides  an  elegant 
explanation of how PA effectors specifically recognize PA 
[29].  In  this  model  a  PA-binding  protein  is  initially 
attracted to a negatively charged membrane bilayer as a 
result  of  electrostatic  interactions.  The  protein  then 
randomly  samples  the  bilayer  until  it  encounters 
protonated PA, which possesses a charge of 1-. Once in 
contact, the basic amino acids of this protein hydrogen 
bond with the phosphomonoester of PA to cause disso-
ciation of its remaining proton (Figure 3b). This results in 
a switch in charge from 1- to 2-, which strengthens the 
electrostatic  interaction  and  locks  the  protein  onto 
deprotonated  PA.  This  unique  property  explains  the 
specificity  of  effectors  for  PA  over  other  negatively 
charged lipids such as PS. The latter has a phosphodiester 
with a maximum charge of 1- (Figure 1) that does not 
Figure 2. Lipid signaling is concentration dependent. Lipid effector proteins are unable to bind membranes when the concentration of 
their target lipid is low (left). Cellular signals lead to the activation of lipid-modifying enzymes, which generate target lipids that can then recruit 
the effector proteins to the membrane (right). Conversely, other cellular signals can activate enzymes that convert the target lipid back to its 
original form or to another lipid, causing release of the effector from the membrane. In this example, the target lipid highlighted in yellow is also 
cone-shaped (for example, PA, PE or DAG) in contrast to the majority of membrane lipids, which are cylindrical in shape (for example, PC and PS; 
headgroups colored brown). The conical shape reduces packing of lipid headgroups, which exposes the hydrophobic acyl layer surrounding the 
target lipid. This may facilitate insertion of hydrophobic amino acids and effector binding.
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Page 3 of 10change  over  the  physiological  range,  making  electro-
static/hydrogen-bond  switching  irrelevant.  Thus,  PA 
effectors  favor  binding  to  PA  over  PS  because  of  the 
higher negative charge of PA and the stronger electro-
static interactions.
The role of arginine as a hydrogen-bond donor in PA-
effector  interaction  is  exemplified  by  work  on  the 
FKBP12-rapamycin binding (FRB) domain of mTOR, one 
of  the  few  characterized  PA-binding  domains  to  have 
been co-crystallized with PA. Veverka et al. [31] crystal-
lized the FRB domain bound to soluble PA containing 
short  acyl  chains.  From  this  crystal  structure,  it  was 
found  that  a  patch  of  only  five  solvent-exposed  amino 
acids were active in PA docking. Of these, only a single 
basic amino acid, an arginine, was absolutely required for 
binding. This agrees with the original characterization of 
PA binding to mTOR, where mutation of this arginine 
significantly inhibited PA binding [15]. Veverka et al. also 
showed  that  the  arginine  is  in  close  proximity  to  the 
headgroup of PA and forms a positively charged patch, 
which the phosphomonoester interacts with. This close 
proximity  should  therefore  allow  hydrogen  bonding 
between the primary amine of arginine and the phospho-
monoester  of  PA,  in  agreement  with  the  electrostatic/
hydrogen-bond switch model [29]. Furthermore, the PA-
binding site in the FRB domain is a shallow pocket that is 
also lined with hydrophobic residues that would be able 
to penetrate into hydrophobic insertion sites surrounding 
PA [31]. The shallowness of the pocket also implies that 
lipids  with  bulkier  headgroups  -  for  example,  PS  and 
PIPs - would encounter steric hindrance, which would 
not be the case for PA.
Lastly, the small cross-sectional area of the phospho-
monoester headgroup of PA relative to the DAG back-
bone gives PA a cone-shaped structure (Figure 2), making 
PA  the  only  cone-shaped  anionic  lipid  in  the  cell  and 
distinguishing  it  yet  further  from  PS,  which  is  a 
cylindrically  shaped  lipid  [32,33].  The  cone  shape 
prevents tight packing of PA’s headgroup with the head-
groups of neighboring lipids, which exposes the hydro-
phobic  acyl  layer  of  the  bilayer  surrounding  PA.  This 
loose packing provides an excellent site for insertion of 
hydrophobic amino acids of PA effectors, which facili-
tates their binding to the membrane (Figure 2) [32,33]. 
For example, PA stimulates penetration of dynamin into 
the acyl layer of membranes even though dynamin does 
not directly bind PA [34].
PE is also a cone-shaped lipid, but differs from PA in 
that it is neutral at physiological pH [32]. As part of their 
work  on  PA  effector  specificity,  Kooijman  et  al.  [29] 
found  that  incorporation  of  PE  into  PA-containing 
liposomes enhanced specific binding of Raf kinase to PA. 
A  role  for  PE  in  PA-effector  binding  was  also  demon-
strated by Young et al. [28] for binding of a transcriptional 
repressor in yeast, Opi1, which will be discussed in more 
detail in the next section. As we saw earlier, one reason 
for the enhancement in binding by PE could be through 
increasing the charge on PA by its role as a hydrogen-
bond donor (Figure 3b); but its conical shape may also 
facilitate the bilayer-insertion of hydrophobic residues of 
PA  effectors,  which  also  contribute  to  binding.  PS,  in 
contrast,  because  of  its  cylindrical  shape,  does  not 
facilitate binding in this way. Together, all these findings 
indicate  that  effector  recognition  of  PA  is  achieved 
through  a  combination  of  electrostatic/hydrogen-bond 
switching  and  the  availability  of  hydrophobic  insertion 
sites in the bilayer surrounding PA.
Phosphatidic	acid	is	a	pH	biosensor	in	yeast
There are two main reasons to suspect that PA could act 
as  an  intracellular  pH  sensor.  First,  the  pKa  of  the 
Figure 3. Hydrogen bonding increases the charge of 
phosphatidic acid (PA) and lysophosphatidic acid (LPA). (a) 
The phosphomonoester headgroup of LPA forms an intramolecular 
hydrogen bond. In the protonated phosphomonoester of LPA (left) 
a proton is shared between two hydroxyl oxygens (purple dashed 
lines). Hydrogen bonding (green dashed lines) between the sn2 
hydroxyl and the phosphomonoester of LPA competes with the 
shared proton for oxygen electrons, which facilitates dissociation of 
the proton lowering the pKa. (b) Hydrogen bonding between the 
phosphomonoester of PA and the primary amine of the headgroup 
of PE, or lysines and arginines of proteins, results in deprotonation 
of the phosphomonoester, lowering its pKa and increasing its 
negative charge. The abundance of PE in cellular membranes is 
likely a significant factor regulating the pKa of both PA and LPA [30]. 
Hydrogen bonding between proteins and PA is described by the 
electrostatic/hydrogen bond switch mechanism [29].
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range (6.9 to 7.9) [30]. The pKa is the negative logarithm 
of the ionization constant (K) of an acid and is equal to 
the pH at which half of the acid molecules are ionized. 
For example, if the pKa of PA is equal to 7, at pH 7 it will 
be  50%  deprotonated.  This  means  that  50%  of  the  PA 
molecules will carry a net charge of 1- and 50% will be 2-. 
If the pH changes one pH unit in either direction, to pH 6 
or  pH  8,  PA  will  be  approximately  90%  protonated  or 
approximately  90%  deprotonated,  respectively.  Thus, 
because of its pKa, PA is poised to change its protonation 
state maximally in response to physiological changes in 
intracellular  pH.  Second,  the  electrostatic/hydrogen-
bond switch mechanism predicts that PA effectors will 
have higher affinity for deprotonated over protonated PA. 
Thus,  protein  effectors  have  the  capacity  to  detect 
changes in the levels of deprotonated PA in response to 
changes in pH, which cells can then exploit in signaling 
pathways. Together, these features suggest that PA is a 
pH biosensor.
Such a role for PA was recently shown by Young et al. 
[28] through a genome-wide screen in yeast to identify 
new  regulators  of  PA  signaling.  In  yeast,  PA  in  the 
endoplasmic  reticulum  regulates  expression  of  genes 
controlling phospholipid synthesis and lipid metabolism. 
It does this through binding and sequestering a trans-
criptional  repressor,  Opi1,  outside  the  nucleus  on  the 
cytoplasmic leaflet of the endoplasmic reticulum. When 
PA  in  the  endoplasmic  reticulum  is  depleted,  Opi1  is 
released  and  translocates  to  the  nucleus,  where  it  co-
ordinately represses transcription of more than 30 genes, 
thus  enabling  global  repression  of  lipid  metabolism 
[24,35]. INO1 is the most highly regulated of these genes 
and is responsible for the synthesis of inositol, which is 
critical  for  the  cell  [35].  Hence,  any  defect  in  binding 
between Opi1 and PA results in the constant repression 
of  INO1  and  the  inability  to  synthesize  inositol.  This 
makes  inositol  auxotrophy  (the  inability  to  grow  in 
medium lacking inositol) an ideal screening phenotype 
for  finding  mutants  with  dysregulated  PA  signaling 
[28,36].
Young et al. [28] discovered that mutants with defects 
in the regulation of cytosolic pH were highly enriched in 
their  inositol  auxotrophy  screen.  The  genes  involved 
included those for both the major regulators of pH in 
yeast - the plasma membrane proton ATPase (Pma1) and 
the  vacuolar  proton  ATPase  (V-ATPase)  [37].  Pma1 
functions as the master regulator of cytosolic pH in yeast 
by pumping protons produced by glycolysis in the cytosol 
out of the cell. In this role, Pma1 consumes nearly 20% of 
total  cellular  ATP  and  is  the  most  abundant  plasma-
membrane protein in yeast [38,39]. The V-ATPase also 
contributes  to  cytosolic  pH  regulation  by  pumping 
protons  from  the  cytosol  into  the  vacuole  and  by 
regulating trafficking of Pma1 to the plasma membrane 
[37]. Thus, mutants defective in either Pma1 or V-ATPase 
activity are sensitive to acidification of the cytosol [37]. 
The normal cytosolic pH of yeast cells is rigorously main-
tained  at  a  pH  around  7.2,  despite  sometimes  harshly 
acidic extracellular conditions [39,40]. Young et al. ex-
ploited a hypomorphic mutant of Pma1 that was incapable 
of  maintaining  physiological  pH  under  conditions  of 
extracellular  acid  stress  and  showed  that  cytosolic 
acidification  correlated  with  repression  of  lipid 
metabolism genes. This was due to the release of Opi1 
from  the  endoplasmic  reticulum  under  conditions  of 
cytosolic acidification. They also showed that binding of 
Opi1 to PA in vitro was dependent on pH, where binding 
decreased with acidification from a pH of around 7 to 
one  of  about  6.  Using  a  non-titratable  methylated 
derivative of PA, Young et al. [28] demonstrated that the 
pH  effect  on  binding  was  due  to  a  change  in  the 
protonation state of PA. Thus, Opi1 has greater affinity 
for deprotonated PA at higher pH, which is consistent 
with  the  electrostatic/hydrogen-bond  switch  model 
(Figure 4).
A remaining question was the physiological function of 
pH-sensing by PA. Yeast are highly sensitive to glucose 
availability  in  their  environment  because  it  is  their 
preferred  energy  source  [41].  One  response  to  glucose 
withdrawal  is  cytoplasmic  acidification,  which  results 
from  the  rapid  inactivation  of  both  Pma1  and  the  V-
ATPase [37,38,42]. Young et al. [28] found that Opi1 was 
released  from  the  endoplasmic  reticulum  and  trans-
located  to  the  nucleus  upon  glucose  starvation.  Opi1 
translocation  was  dependent  on  cytoplasmic  pH  and 
correlated with a drop below a pH of around 6.9, consis-
tent with the decreased affinity of Opi1 for protonated 
PA. Thus, PA is a pH biosensor that coordinates nutrient 
sensing  and  cell-growth  signaling  by  regulating  the 
synthesis of new membranes.
pH	sensing	by	phosphatidic	acid	in	animal	cells
The appropriate cytosolic pH must be rigorously main-
tained in all cells, not just those of yeast, because of the 
massive generation of protons and other metabolic acids 
by  core  metabolic  processes  [39,43].  Although  pH-
sensing by PA in yeast has now been demonstrated, a key 
question  is  how  relevant  are  lipid  pH  biosensors  to 
signaling and metabolic regulation in animals. In most 
animal cells, cytosolic pH is primarily regulated by Na+/
H+ exchangers in the plasma membrane, which export 
protons  from  the  cytoplasm  through  passive  exchange 
with extracellular Na+ generated by Na+K+-ATPases [43]. 
Maintaining  a  distinct  cytoplasmic  pH  is  essential  for 
optimal  cellular  metabolism,  growth  and  proliferation 
[43,44]. Cytoplasmic acidification, for example, results in 
the blockage of secretion and endocytosis and prevents 
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Cytoplasmic acidification is also linked to induction of 
apoptotic  pathways  and  has  important  ties  to  cancer 
[44,48].  Along  with  regulating  bulk  cytoplasmic  pH, 
localized  Na+/H+  exchanger  activity  in  regions  of  the 
plasma membrane also generates alkalinized pH micro-
domains  that  regulate  the  actin  cytoskeleton  and  are 
necessary for cell polarization [49-51]. Increased Na+/H+ 
exchanger  activity  in  the  growth  cone  of  neurons 
compared with the cell body causes elevated local cyto-
plasmic  pH,  which  results  in  increased  polarization/
extension of neurites [51]. Na+/H+ exchanger activity is 
also  upregulated  in  post-synaptic  membranes  during 
neuronal activity where it negatively regulates dendritic 
spine growth [52]. Increased Na+/H+ exchanger localiza-
tion to this membrane lowers the extracellular pH of the 
synaptic  cleft,  which  inhibits  pH-sensitive  synaptic 
proteins that are responsible for spine growth, while at 
the same time alkalinizing cytoplasmic pH locally [52].
The  intracellular  pH  of  organelles  varies  widely.  The 
endoplasmic reticulum, nucleus and peroxisomes lack an 
intrinsic pH regulatory system and are instead indirectly 
regulated by Na+/H+ exchanger activity. Therefore, these 
organelles  possess  an  intracellular  pH  of  around  7.2, 
equivalent to that of the cytosol [39,43]. Mitochondria, in 
contrast, have an alkaline intracellular pH of around 8 
that is maintained by the extrusion of protons across the 
inner mitochondrial membrane as a result of respiratory 
chain activity [43]. The intracellular pH of secretory and 
endocytic  organelles  becomes  increasingly  acidified 
along their pathways. For example, the luminal pH along 
the  pathway  from  endoplasmic  reticulum  to  secretory 
granule progressively decreases from around 7.2 to 5.5, 
while the difference in pH between early endosomes and 
lysosomes  decreases  from  around  6.3  to  4.7  [43].  This 
gradual acidification is thought to result from a combi-
nation  of  two  factors.  First,  the  activity  of  V-ATPases 
found  in  these  organelles  may  increase  progressively 
through these pathways, resulting in higher proton accu-
mulation and acidification [39,43]. Second, the degree of 
membrane permeability to protons and counter-ions may 
decrease progressively in these pathways, also contribut-
ing to lowering of luminal pH [43].
That  intracellular  pH  is  tightly  regulated,  and  that  a 
particular pH can exist as cytoplasmic microdomains in 
response  to  stimuli  or  through  intracellular  compart-
mentalization  by  organelles,  implies  that  lipid  pH  bio-
sensors  such  as  PA  could  have  important  roles  in  this 
regulation.  The  work  of  Simons  et  al.  [53]  provides  a 
tantaliz  ing  first  glimpse  into  a  probable  role  for 
Figure 4. Phosphatidic acid is a pH biosensor. Effector proteins bind PA according to the electrostatic/hydrogen-bond switch mechanism 
[29]. Electrostatic interactions and hydrogen bonding (green dashed lines) between the primary amines of basic amino acids in the effector and 
the deprotonated phosphomonoester of PA are shown. A decrease in intracellular pH below the pKa of PA results in increased protonation of its 
phosphomonoester, which reduces the strength of electrostatic interactions with the effector, resulting in its dissociation from the membrane.
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Drosophila.  As  part  of  a  well-defined  Wnt-signaling 
pathway, the protein dishevelled (Dsh) is recruited to the 
plasma  membrane  by  frizzled  (Fz)  to  facilitate  the 
development  of  planar  cell  polarity,  which  is  also 
important  in  the  embryonic  development  of  animals 
other  than  the  fly  [54].  Simons  et  al.  performed  a 
genome-wide RNA interference screen in Drosophila to 
identify genes required to maintain recruitment of a Dsh-
green  fluorescent  protein  fusion  to  the  plasma  mem-
brane. Involvement of pH was shown as recruitment of 
Dsh was lost in Na+/H+ exchanger knockdown mutants, 
which had altered cytoplasmic pH. A role for PA in this 
process is suggested by the binding of a basic domain of 
Dsh to PA in vitro through a cluster of basic amino acids 
that are also required for Dsh membrane localization in 
vivo.  Consistent  with  the  electrostatic/hydrogen-bond 
switch mechanism, this work [53] strongly implies that 
Dsh  binds  to  deprotonated  PA  in  vivo,  binding  that  is 
dependent on cytoplasmic pH and the protonation state 
of  the  lipid.  Dsh  recruitment  by  PA  in  vivo  was  not 
demonstrated in this study, but it is exciting to speculate 
that PA has a role as a pH biosensor in the regulation of 
planar cell polarity in fly and other animal cells.
Targeting	phosphatidic	acid	effectors	to	membranes
Phosphatidic acid is present at low levels in virtually all 
cellular membranes [28,55]. However, PA effectors often 
localize  exclusively  to  specific  intracellular  membranes 
[12,20,24,56]. An important question then is how is PA in 
a particular membrane recognized over PA in another? 
One obvious mechanism is for the cell to generate locally 
higher  concentrations  of  PA,  which  facilitate  effector 
recruitment. As mentioned earlier, regulated activation 
of  enzymes  such  as  PLD  and  DGK  in  a  particular 
membrane is sufficient to provide such a signal for the 
recruitment  of  effectors  such  as  the  Raf  and  mTOR 
kinases [3]. And of course, regulating the localization of 
the  lipid-modifying  enzymes  is  a  prerequisite.  A  clear 
example again comes from yeast, in which PLD changes 
its  localization  from  being  diffusely  cytoplasmic  in 
vegetative  cells  to  localizing  to  prospore  membranes 
during sporulation [21].
PA effectors can also be targeted to specific membranes 
through cooperative binding of the lipid with additional 
cofactors, such as membrane-anchored proteins or other 
lipids [1,23]. Opi1, for example, binds and senses changes 
in PA in the endoplasmic reticulum of yeast specifically 
by  binding  to  the  integral  endoplasmic  reticulum 
membrane protein Scs2 in addition to PA [24]. In fact, 
deletion  of  SCS2  results  in  release  of  Opi1  from  the 
endoplasmic  reticulum  and  its  translocation  to  the 
nucleus, which indicates that binding to PA alone is not 
sufficient to retain it on the endoplasmic reticulum [57]. 
When the PA-binding domain of Opi1 is expressed on its 
own in yeast it localizes to the plasma membrane, the 
location of the predominant pool of PA in yeast [24,55]. 
Thus, Scs2 is a cofactor that tethers Opi1 to the endo-
plasmic  reticulum,  enabling  Opi1  to  sense  PA  there. 
Several PA effectors also contain additional binding sites 
for other lipids, such as the PIPs [23]. As we discuss later, 
this important class of signaling lipids comes in a variety 
of forms, with each form localized to a particular intra-
cellular  membrane  [58].  The  use  of  PIPs  as  cofactors 
should also enable tethering of PA effectors to particular 
membranes,  but  studies  are  needed  to  test  this 
hypothesis.
The  overall  lipid  composition  of  membranes  is  also 
likely  to  be  important  for  targeting.  First,  the  electro-
static/hydrogen-bond  switch  model  predicts  an  impor-
tant  role  for  membrane-lipid  composition  on  the 
localization of PA effectors. PE makes up around 15% of 
total phospholipids in yeast, but is distributed in widely 
varying ratios from membrane to membrane [28,55,59]. 
For example, the inner leaflet of the plasma membrane 
and  the  cytoplasmic  leaflet  of  the  Golgi  have  higher 
PE:PC  ratios  than  most  other  intracellular  membranes 
[7,55,59]. As described earlier, higher PE in these mem-
branes would increase hydrogen bonding to the phospho-
monoester  of  PA,  thus  increasing  its  overall  negative 
charge. Second, more PE would allow better penetration 
of PA effectors into membranes, because of the increase 
in  hydrophobic  insertion  sites  caused  by  the  conical 
shape  of  PE.  The  dual  effects  of  PE  will  enhance  the 
recognition of PA in these particular membranes.
Overall membrane surface charge is also likely to be a 
significant  membrane-targeting  factor.  Using  cationic 
fluorescent  peptide  probes  to  study  membrane  charge 
density, Yeung et al. [60] clearly demonstrated that intra-
cellular  membranes  are  negatively  charged  in  varying 
degrees of strength. Of these, the cytosolic surface of the 
plasma membrane is the most negatively charged, due to 
the large amount of PS and PIPs [7,60]. Yeung et al. [60] 
found that their most cationic peptide probes (8+) bound 
predominantly to the plasma membrane, while probes of 
decreasing  cationic  charge  (6+  to  2+)  bound  to  intra-
cellular membranes of correspondingly decreasing nega-
tive membrane surface charge. These fascinating findings 
raise the possibility that individual PA effectors may be 
fine-tuned to bind membranes of a particular net charge 
by the number and density of basic versus acidic residues 
they possess.
On the basis of the electrostatic/hydrogen-bond switch 
mechanism,  changes  in  intracellular  pH  are  likely  to 
affect the membrane-targeting of effectors that employ 
all the mechanisms described above. Most significant will 
be the lowering of pH below the pKa of PA, which will 
result in stable protonation of PA and decreased effector 
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increases in local PA concentration due to enzyme action 
(for example, of PLD), as at low pH the effectors will have 
greatly reduced affinity for PA. Because lipid and protein 
composition  varies  between  cellular  membranes,  and 
both are factors that fine-tune the pKa of PA, the effects 
of changes in pH on effector binding will depend on the 
pKa of PA in that particular membrane environment. For 
example, membranes that are rich in PE will lower the 
pKa of PA and thus reduce pH effects on effector binding 
over the neutral pH range, but may enhance pH effects in 
more acidic compartments.
Can	phosphoinositides	act	as	pH	sensors	as	well?
Along with PA, phosphomonoesters are found in other 
membrane  lipids,  including  PIPs  and  certain  sphingo-
lipids [61,62]. PIPs are probably the best characterized 
class of membrane signaling lipids, and they regulate a 
multitude  of  important  cellular  processes  [1,58,63]. 
Differ  ent PIPs are uniquely defined by phosphorylation of 
the  inositol  ring  headgroup  at  different  positions  in 
varying combinations. PIPs have an important function 
as biomarkers for membrane recognition that helps define 
intracellular  membrane  compartments  and  localize 
organelle-specific  activities.  This  is  achieved  through 
tight spatiotemporal regulation of their concentration by 
enzymes located in the particular membranes. Generally, 
PI(4,5)P2 is enriched in the plasma membrane, PI(4)P in 
the  Golgi,  and  PI(3)P  and  PI(3,5)P2  in  the  endosomal 
system,  thus  enabling  clear  recognition  of  these  mem-
branes  by  the  cellular  machinery  [58].  PI(4,5)P2  in  the 
plasma membrane is a major regulator of endocytosis, 
cytoskeletal attachment and calcium release in the cell 
[64]. PI(4)P has important functions in the Golgi, where 
it is required for vesicle budding and secretion [63]. In 
endosomal membranes, generation of PI(3)P and PI(3,5)
P2  acts  as  an  important  sorting  signal  for  intracellular 
membrane trafficking [58].
But can PIPs act as pH sensors? The pKa values of the 
phosphomonoester  headgroups  of  various  PIPs  have 
been measured using 31P-NMR in model membranes and 
range from around 6 to around 8 [62,65]. Of these, the 
most  acidic  is  PI(4)P  with  a  pKa  of  around  6.2,  which 
should still titrate over physiological pH, but is possibly 
fine-tuned  for  more  acidic  compartments,  consistent 
with  its  important  function  at  the  Golgi  [65].  Of  the 
polyphosphoinositides, Kooijman et al. [62] were able to 
measure the pKa values for the 3’ and 5’ phosphates of 
PI(3,5)P2,  which  are  around  7.0  and  6.6,  respectively. 
Similarly,  PI(4,5)P2  has  a  pKa of  around  6.5  in  its  4’ 
phosphate;  the  5’  phosphate  could  not  be  accurately 
measured,  but  is  within  the  physiological  range  [65]. 
Thus,  these  PIPs  are  poised  to  titrate  with  changes  in 
intra  cellular  pH  and  will  become  protonated  as 
intracellular pH drops, similarly to PA. The differences in 
ionization behavior of the different PIPs can be explained 
largely on the basis of the electrostatic/hydrogen-bond 
switch mechanism [62].
If PIPs are to act as pH biosensors, then their protein 
effectors must discriminate between the various charged 
forms and follow the rules of the electrostatic/hydrogen-
bond  switch  mechanism.  Canonical  protein  effectors 
bind to PIPs generally through structurally evolutionarily 
conserved  binding  domains,  such  as  PH,  PX,  FYVE, 
ENTH  and  ANTH  [1].  Non-canonical  PIP-binding 
domains are also being found [66-69]. How these domains 
recognize these lipids varies greatly and includes combi-
nations of ‘specific’ binding through distinct PIP-binding 
pockets, ‘nonspecific’ binding through electrostatic and 
hydrophobic  interactions,  and  contributions  from  the 
physical  properties  of  the  membrane  -  for  example, 
membrane curvature [1]. However, a common element 
shared with all binding domains is the requirement for 
electrostatic interaction with the phosphomonoesters of 
the  lipids.  Because  PIPs  also  titrate  within  the  physio-
logical range, it is likely that at least some of these lipid-
protein interactions will be pH-dependent as a result of 
the protonation state of the lipid.
But  is  there  evidence  for  pH-dependent  binding  to 
PIPs? There are indeed examples, but in these cases the 
pH sensor is the protein rather than the lipid [70]. For 
example, ENTH, ANTH, and FYVE domains have been 
found to possess a critical pair of histidines in their PIP-
binding  sites,  known  as  a  ‘histidine  switch’.  Like  PA, 
histidines also possess a pKa within physiological range, 
which enables their protonation with decreasing intra-
cellular  pH  [71,72].  Protonation  increases  the  overall 
positive  charge  of  the  effector,  which  enables  stronger 
electrostatic  interaction  with  the  PIP  and  thus  higher 
affinity  at  low  pH  [71,72].  Although  the  protein  is  the 
sensor in this case, the histidine switch sets a precedent 
that  small  changes  in  ionization  strengths  can  indeed 
influence  effector  binding.  Optimistically,  therefore,  it 
seems possible that changes in pH that alter the charge 
state of PIPs may also regulate binding. In the simplest 
case, such interactions are likely to be with effectors that 
lack histidine switches, although a combination of both 
could provide additional regulation or fine-tuning.
To sum up, intracellular pH is precisely regulated in 
cells to ensure proper cellular physiology. Evolution has 
elegantly exploited the simple chemistry of the phospho-
monoester to enable lipids to act as pH biosensors. The 
discovery  that  lipids  act  as  pH  biosensors  provides  a 
simple  general  mechanism  for  cells  to  monitor  and 
rapidly  respond  to  changes  in  pH.  For  example,  pH 
changes may signal changes in cellular metabolism, res-
ponse to nutrients or other growth signals, intracellular 
transport or even pathogenic states, such as infection and 
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switch mechanism presented by Kooijman et al. [29], the 
unique  ability  of  the  phosphomonoester  to  form 
hydrogen  bonds  with  lipids  and  proteins  is  both  the 
source  of  its  physiological  pH-sensing  capabilities  and 
also provides the mechanism for pH-dependent effector 
binding. In the case of PA, protein effectors have evolved 
to  sense  both  the  charged  state  of  PA  as  well  as  its 
loosening  effect  on  the  hydrophobic  property  of  the 
membrane surface, and it is these properties combined 
that allow specific recognition of PA over other anionic 
lipids in membranes. The presence of other membrane-
targeting  determinants  in  PA  effectors  provides  addi-
tional specificity in their targeting to individual cellular 
membranes. An intriguing and important question that 
remains  is  whether  other  membrane  lipids  containing 
phosphomonoesters, such as PIPs, ceramide-1-phosphate, 
and  diacylglycerol  pyrophosphate,  also  function  as  pH 
biosensors.  Given  their  physiological  pKa  values,  these 
lipids  undoubtedly  can  detect  pH  changes  in  cells. 
However, it remains an open question whether evolution 
once  again  has  exploited  electrostatic/hydrogen-bond 
switch  chemistry  for  effector  protein  binding,  thus 
making these lipids true pH biosensors.
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